David is a very experienced CMO. I don't think any DXB shareholders should be worried with this change. In my opinion David would not join DXB if he had concerns about the company or the current Phase 3 trial.
Ann: Dimerix Appoints Chief Medical Officer, page-4
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
-0.010(2.60%) |
Mkt cap ! $208.9M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 37.0¢ | $687.3K | 1.820M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 411730 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 177132 | 5 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| DXB (ASX) Chart |